ECONOMICS IN CLINICAL GUIDELINES- A COST-EFFECTIVENESS ANALYSIS OF REPOSITIONING STRATEGIES FOR THE PREVENTION OF PRESSURE ULCERS
Author(s)
Marsden G1, Jones K2, Neilson J2, Stansby G3, Collier M4, Avital L2
1Office of Health Economics, London, UK, 2National Clinical Guideline Centre, London, UK, 3Freeman Hospital, Newcastle upon Tyne, UK, 4United Lincolnshire Hospitals NHS Trust, Lincoln, UK
METHODS: The clinical inputs to the model were taken from the systematic review of clinical data conducted for the guideline. The model population was elderly people in a nursing home; this represents a group at high risk of developing a PU. The economic model was developed in consultation with members of the guideline development group (GDG), and took the perspective of the UK National Health Service. Outcomes were expressed as costs and quality adjusted life years (QALYs).
RESULTS: Despite being marginally more clinically effective, 2 and 4 hourly repositioning is not cost-effective (compared to 4 hourly repositioning) for this high risk group of patients at a cost-effectiveness threshold of £20,000 per QALY. The ICER was £1,854,070 per QALY.
CONCLUSIONS:
FUNDING: This work was undertaken by the National Clinical Guideline Centre, which received funding from NICE. The views expressed in this publication are those of the authors and not necessarily of the institute.
Conference/Value in Health Info
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PSS24
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Sensory System Disorders